Costimulatory Pathways in Rheumatoid Synovitis and T‐Cell Senescence
- 1 December 2005
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1062 (1) , 182-194
- https://doi.org/10.1196/annals.1358.022
Abstract
The pathogenesis of rheumatoid arthritis (RA) is determined by a complex interaction of genetic and environmental factors. Of all risk factors, age has the largest impact. RA occurs most often during the postmenopausal period of life, with incidence rates peaking in the eighth decade. While age is generally accepted as an etiologic factor for failure of immunocompetence, much less is understood about the role of T-cell senescence in autoimmunity. We have hypothesized that senescent T cells are particularly prone to be activated in specialized microenvironments, such as the synovial membrane. CD4 T cells in the senescence program were identified by the loss of CD28. Gene expression profiling documented that CD28- T cells have acquired a spectrum of regulatory receptors that are usually seen only on NK cells. Such regulatory receptors include stimulatory and inhibitory members of the killer immunoglobulin-like receptor (KIR) family, the stimulatory c-type lectin receptor NKG2D, and CX3CR1, the receptor for the chemokine fractalkine. Synovial fibroblasts express the relevant ligands, thus providing stimulatory signals to tissue-infiltrating T cells. The signaling pathways of these regulatory receptors are complex and dependent on the individual T cells, some of which express important adapter molecules such as DAP10 and DAP12. Inhibitory KIRs on T cells are often only partially functional. Our data suggest that, by virtue of altered receptor profiles, conventional tolerance mechanisms can be evaded in the aging host. By acquiring a new set of regulatory receptors, senescent CD4 T cells become responsive to novel environmental cues and find ideal stimulatory conditions in the synovial microenvironment.Keywords
This publication has 48 references indexed in Scilit:
- Modulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritisArthritis & Rheumatism, 2005
- T cell costimulation by fractalkine‐expressing synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2005
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005
- Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseasesCurrent Opinion in Biotechnology, 2004
- The double life of NK receptors: stimulation or co-stimulation?Trends in Immunology, 2004
- Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular CytotoxicityMolecular and Cellular Biology, 2003
- Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)The Journal of Experimental Medicine, 2003
- Molecular Basis for the Loss of CD28 Expression in Senescent T CellsPublished by Elsevier ,2002
- Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblingsArthritis & Rheumatism, 1996
- New roles for rheumatoid factor.Journal of Clinical Investigation, 1991